A study for a 58 year old woman who takes Cosentyx - from FDA reports


Summary

708 females aged 58 (±5) who take the same drug are studied. This is a personalized study for a 58 year old female patient who has Psa. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Jun, 19, 2017

708 females aged 58 (±5) who take Cosentyx are studied.


Number of reports submitted per year:

Cosentyx for a 58-year old woman.

Information of the patient in this study:

  • Age: 58
  • Gender: female
  • Conditions: Psa
  • Drugs taken:
    • Cosentyx (secukinumab)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • rashes
  • psoriasis
  • malaise
  • hypoaesthesia
  • back pain
  • breathing difficulty
  • migraine
  • feeling abnormal
  • diarrhea
  • cough
1 - 6 months:
  • psoriasis
  • rashes
  • drug ineffective
  • diarrhea
  • psoriatic arthropathy
  • pain
  • sepsis
  • fatigue
  • joint pain
  • headache
6 - 12 months:
  • drug ineffective
  • glaucoma
  • blood lactate dehydrogenase increased
  • aspartate aminotransferase increased
  • agranulocytosis
  • weakness
  • anion gap increased
  • blood alkaline phosphatase increased
  • troponin increased
  • gamma-glutamyltransferase increased
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • psoriasis
  • rashes
  • nasopharyngitis
  • pain
  • drug ineffective
  • diarrhea
  • malaise
  • joint pain
  • itching
  • fatigue

Top conditions involved for these people *:

  • Psoriasis (455 people, 64.27%)
  • Psoriatic Arthropathy (82 people, 11.58%)
  • Ankylosing Spondylitis (30 people, 4.24%)
  • High Blood Pressure (9 people, 1.27%)
  • Rheumatoid Arthritis (8 people, 1.13%)

Top co-used drugs for these people *:

  • Enbrel (22 people, 3.11%)
  • Metformin (13 people, 1.84%)
  • Humira (12 people, 1.69%)
  • Methotrexate (9 people, 1.27%)
  • Cymbalta (9 people, 1.27%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Psa, Cosentyx

You may be interested in these reviews

More reviews for: Psa, Cosentyx